Cover Image

Evaluation of the power of six clustering features in identifying a homogeneous disease subset in juvenile idiopathic arthritis (JIA)

Saved in:

Bibliographic Details
Main Authors:	Magnani A (Author), Oliveira S (Author), Castell E (Author), Arguedas O (Author), Ullmann N (Author), Pederzoli S (Author), Manzoni S Magni (Author), Pistorio A (Author), Ruperto N (Author), Martini A (Author), Ravelli A (Author)
Format:	Book
Published:	BMC, 2008-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Time of onset of iridocyclitis (IC) in children with juvenile idiopathic arthritis (JIA)
by: Verazza S, et al.
Published: (2008)

Development and initial validation of the parent acceptable symptom state in juvenile idiopathic arthritis (JIA)
by: Filocamo G, et al.
Published: (2008)

A meta-analysis to estimate the "real" placebo effect in juvenile idiopathic arthritis (JIA) trials
by: Martini A, et al.
Published: (2011)

Final validation of a new composite disease activity score for juvenile idiopathic arthritis: the Juvenile Arthritis Disease Activity Score (JADAS)
by: Consolaro A, et al.
Published: (2008)

Impact of involvement of individual joint groups on subdimensions of functional ability scales in juvenile idiopathic arthritis
by: Meiorin S, et al.
Published: (2008)

Analysis of ceiling effect and score distribution of outcome measures in juvenile idiopathic arthritis (JIA)
by: Lattanzi B, et al.
Published: (2008)

Agreement between objective and subjective definitions of inactive disease, remission and minimal disease activity in juvenile idiopathic arthritis
by: Davì S, et al.
Published: (2011)

Comparison of the accuracy of different definitions of clinical remission (CR) and minimal disease activity (MDA) in juvenile idiopathic arthritis (JIA)
by: Davì S, et al.
Published: (2008)

Infliximab to treat chronic uveitis in juvenile idiopathic arthritis (JIA)
by: Bracaglia C, et al.
Published: (2008)

Juvenile idiopathic arthritis (JIA): can an integrated medicine be possible?
by: Carlomagno R, et al.
Published: (2011)

Comparison of physician's, parent's and patient's global ratings made on linear or 21-circle visual analogue scales (VAS) in juvenile idiopathic arthritis (JIA)
by: Dalprà S, et al.
Published: (2008)

Adalimumab and severe uveitis in juvenile idiopathic arthritis (JIA) therapy
by: Alpigiani MG, et al.
Published: (2008)

Thalidomide: efficacy and side effects in juvenile idiopathic arthritis (JIA)
by: Alpigiani MG, et al.
Published: (2008)

14.4 Oligoarticular Juvenile Idiopathic Arthritis (JIA): can extension be predicted?
by: Hunter PJ, et al.
Published: (2008)

Children with juvenile idiopathic arthritis currently followed in a tertiary care setting have a better psychosocial well-being than healthy peers
by: Suffia C, et al.
Published: (2011)

Replication of the association of the <it>COG6</it> gene with juvenile idiopathic arthritis (JIA)
by: Worthington J, et al.
Published: (2011)

Mandibular condyle destruction in juvenile idiopathic arthritis (JIA)
by: Zak M, et al.
Published: (2008)

Agreement between physicians and parents in rating functional ability of children with juvenile idiopathic arthritis
by: Buoncompagni Antonella, et al.
Published: (2007)

Investigating the use of a limited core outcome variable set for the classification of response following methotrexate treatment in juvenile idiopathic arthritis (JIA)
by: Hirani SP, et al.
Published: (2008)

Preliminary validation of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) in 403 clinic patients
by: Solari N, et al.
Published: (2008)

How do parents of children with juvenile idiopathic arthritis (JIA) perceive their therapies?
by: Nageswaran Savithri, et al.
Published: (2008)

4.4 Different phenotype of anaemia in systemic juvenile idiopathic arthritis (s-JIA) compared to anaemia in other subtypes of JIA
by: Hinze CH, et al.
Published: (2008)

Current Treatments for Juvenile Idiopathic Arthritis
by: Alberto eMartini, et al.
Published: (2011)

Do parent's global rating of well-being and disease activity of children with juvenile idiopathic arthritis yield different information?
by: Ullmann N, et al.
Published: (2008)

Multicentric Castleman's Disease (CD) in juvenile idiopathic arthritis (JIA) treated with etanercept: coincidence or causal relationship?
by: Rossi L, et al.
Published: (2008)

Rituximab in ANA positive polyarticular juvenile idiopathic arthritis (JIA) with uveitis
by: Baildam EM, et al.
Published: (2008)

Development and initial validation of a new short and simple Health-Related Quality Of Life (HRQL) Questionnaire for Pediatric Rheumatic Diseases (PRD)
by: Palmisani E, et al.
Published: (2008)

Notice of redundant publication: Aerobic capacity and disease activity in children, adolescents and young adults with juvenile idiopathic arthritis (JIA)
by: Martini Alberto, et al.
Published: (2013)

Aerobic capacity and disease activity in children, adolescents and young adults with juvenile idiopathic arthritis (JIA)
by: van Pelt Philomine A, et al.
Published: (2012)

Aerobic capacity and disease activity in children, adolescents and young adults with juvenile idiopathic arthritis (JIA)
by: van Pelt Philomien A, et al.
Published: (2012)

Investigating which variables from the core outcome variables in juvenile idiopathic arthritis (JIA) are the best predictors of classification as a responder to treatment with methotrexate (MTX)
by: Hirani SP, et al.
Published: (2008)

The successes and challenges of harmonising juvenile idiopathic arthritis (JIA) datasets to create a large-scale JIA data resource
by: Saskia Lawson-Tovey, et al.
Published: (2023)

Psychological characteristics of the patients with juvenile idiopathic arthritis (JIA) of various age groups
by: Stepanenko NY
Published: (2011)

Osteoblast differentiation from synovial fluid cells in juvenile idiopathic arthritis (JIA)
by: Jelusic-Drazic Marija, et al.
Published: (2012)

Adalimumab treatment in Juvenile Idiopathic Arthritis (JIA) patients with special focus on Uveitis
by: Dehoorne J, et al.
Published: (2011)

Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (sJIA): TENDER 52-week data
by: De Benedetti Fabrizio, et al.
Published: (2012)

A new approach to defining inactive disease, minimal disease activity and parent- and child-acceptable symptom state in juvenile idiopathic arthritis
by: Bertamino M, et al.
Published: (2011)

2.4 Magnetic resonance imaging, ultrasonography and conventional radiography in the assessment of bone erosions in juvenile idiopathic arthritis
by: Malattia C, et al.
Published: (2008)

2.1 Long-term safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis (JIA)
by: Yokota S, et al.
Published: (2008)

Efficacy of a second TNF blocker, when the first one failed, in patients with juvenile idiopathic arthritis (JIA)
by: Salmaso A, et al.
Published: (2008)